360 related articles for article (PubMed ID: 21837801)
1. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
[TBL] [Abstract][Full Text] [Related]
3. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B; Björkstén B
Pediatrics; 1995 Apr; 95(4):500-5. PubMed ID: 7700748
[TBL] [Abstract][Full Text] [Related]
4. [Detection of respiratory syncytial virus in children with respiratory tract infections by nucleic acid amplification fluorogenic quantitative assay].
Tan ZT; Shi L; Lu GX; Xu W; Jia YP; Xing Y; Wu XL; Hu S; Ren Y; Wu LX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):825-8. PubMed ID: 19849942
[TBL] [Abstract][Full Text] [Related]
5. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus (RSV) antibodies in different immunoglobulin classes in small children.
Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
Acta Microbiol Pol; 1994; 43(3-4):359-68. PubMed ID: 7740986
[TBL] [Abstract][Full Text] [Related]
7. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
Groothuis JR; Hoopes JM; Hemming VG
Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador.
Colocho Zelaya EA; Pettersson CA; Forsgren M; Orvell C; Strannegard O
Am J Trop Med Hyg; 1994 Nov; 51(5):577-84. PubMed ID: 7985749
[TBL] [Abstract][Full Text] [Related]
9. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL
Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934
[TBL] [Abstract][Full Text] [Related]
10.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
11. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus.
Larrañaga CL; Ampuero SL; Luchsinger VF; Carrión FA; Aguilar NV; Morales PR; Palomino MA; Tapia LF; Avendaño LF
Pediatr Infect Dis J; 2009 Oct; 28(10):867-73. PubMed ID: 19738511
[TBL] [Abstract][Full Text] [Related]
12. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
13. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan.
Kaneko M; Watanabe J; Kuwahara M; Ueno E; Hida M; Kinoshita A; Sone T
J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731
[TBL] [Abstract][Full Text] [Related]
14. Human metapneumovirus infection in hospital referred South African children.
IJpma FF; Beekhuis D; Cotton MF; Pieper CH; Kimpen JL; van den Hoogen BG; van Doornum GJ; Osterhaus DM
J Med Virol; 2004 Jul; 73(3):486-93. PubMed ID: 15170647
[TBL] [Abstract][Full Text] [Related]
15. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
Jans J; Wicht O; Widjaja I; Ahout IM; de Groot R; Guichelaar T; Luytjes W; de Jonge MI; de Haan CA; Ferwerda G
PLoS One; 2017; 12(1):e0170877. PubMed ID: 28135305
[TBL] [Abstract][Full Text] [Related]
17. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
Walsh EE; Falsey AR
J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
[TBL] [Abstract][Full Text] [Related]
18. Similar cytokine profiles in response to infection with respiratory syncytial virus type a and type B in the upper respiratory tract in infants.
Bermejo-Martin JF; Tenorio A; Ortiz de Lejarazu R; Eiros JM; Matías V; Dominguez-Gil M; Pino M; Alonso A; Blanco-Quiros A; Arranz E; Ardura J
Intervirology; 2008; 51(2):112-5. PubMed ID: 18493154
[TBL] [Abstract][Full Text] [Related]
19. Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants.
Watt PJ; Zardis M; Lambden PR
Clin Exp Immunol; 1986 Jun; 64(3):503-9. PubMed ID: 3791688
[TBL] [Abstract][Full Text] [Related]
20. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
